Recent Updates
Recently added Catalysts
NAGE Positive Sentiment

Niagen Bioscience Announces Participation in Upcoming Investor Conferences

Monday, November 9, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Niagen Bioscience announced its participation in upcoming investor conferences. The events include the A.G.P. Virtual Consumer Showcase, scheduled for November 11-12, 2026. This showcases the company's commitment to engaging with the investment community and sharing its focus on healthy aging.

Market Sentiment Analysis

POSITIVE FACTORS

  • Niagen Bioscience is participating in key investor conferences.
  • The company focuses on the science of healthy aging.
  • Leadership engagement with the investment community is planned.

Full Press Release Details

LOS ANGELES--(BUSINESS WIRE)---- $NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior leadership will participate in the following upcoming conferences: A.G.P. Virtual Consumer Showcase Virtual showcase offering consumer company management teams a platform to share their story with the investment community Location: Virtual Date: November 11 - 12, 2026 Format: Fireside chat

Frequently Asked Questions

What conferences will Niagen Bioscience attend?

Niagen Bioscience will attend the A.G.P. Virtual Consumer Showcase.

When is the A.G.P. Virtual Consumer Showcase?

The showcase is scheduled for November 11-12, 2026.

What is the focus of Niagen Bioscience?

The company focuses on the science of healthy aging.

Who will participate in the conferences?

Senior leadership from Niagen Bioscience will participate.

ShareAdd on Google
Tags: NAGE NAD+ healthy aging investor conferences Niagen Bioscience A.G.P. Virtual Consumer Showcase
Last updated: Nov 9, 2026

Biotech snapshot

Cash runway
$70M liquidity · $0M/mo burn
Low dilution risk
Lead asset
NiagenPlusPhase 1
Fatigue →